<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cerebral protective effects of <z:chebi fb="0" ids="51038">minaprine</z:chebi> were examined using the following methods, i.e., complete <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by decapitation in mice, histotoxic <z:mp ids='MP_0002316'>anoxia</z:mp> by <z:chebi fb="8" ids="33191">potassium cyanide</z:chebi> (<z:chebi fb="0" ids="33191">KCN</z:chebi>) in mice, hypobaric <z:mp ids='MP_0005039'>hypoxia</z:mp> in mice, asphyxic <z:mp ids='MP_0002316'>anoxia</z:mp> in <z:mpath ids='MPATH_458'>normal</z:mpath> rats and <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCAO) in strokeprone spontaneously hypertensive rats (SHR-SP) </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="51038">Minaprine</z:chebi> showed positive effects on <z:hpo ids='HP_0000001'>all</z:hpo> the mouse models </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="51038">Minaprine</z:chebi> led to an improvement in the <z:mp ids='MP_0005039'>hypoxia</z:mp>-induced impaired electroencephalogram activity, in <z:mpath ids='MPATH_458'>normal</z:mpath> rats </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> vehicle-treated SHR-SP died within 20 hr after BCAO, whereas pretreatment with <z:chebi fb="0" ids="51038">minaprine</z:chebi> (50 mg/kg x 5 days) decreased the mortality within 20 hr after BCAO </plain></SENT>
<SENT sid="4" pm="."><plain>Beneficial effects of <z:chebi fb="0" ids="51038">minaprine</z:chebi> for treating cerebral <z:mp ids='MP_0005039'>hypoxia</z:mp>, <z:mp ids='MP_0002316'>anoxia</z:mp> and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> are discussed </plain></SENT>
</text></document>